Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase - PubMed (original) (raw)
. 2001 Mar;114(Pt 6):1213-20.
doi: 10.1242/jcs.114.6.1213.
Affiliations
- PMID: 11228164
- DOI: 10.1242/jcs.114.6.1213
Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase
D Nath et al. J Cell Sci. 2001 Mar.
Erratum in
- J Cell Sci. 2014 Apr;127(Pt 7):1620
Abstract
A wide repertoire of transmembrane proteins are proteolytically released from the cell surface by a process known as 'ectodomain shedding', under both normal and pathophysiological conditions. Little is known about the physiological mechanisms that regulate this process. As a model system, we have investigated the metalloproteinase-mediated cleavage of the hepatocyte growth factor receptor, Met. We show that epidermal growth factor (EGF) receptor activation, either directly by EGF or indirectly via the G-protein coupled receptor (GPCR) agonist lysophosphatidic acid (LPA), induces cleavage of Met through activation of the Erk MAP kinase signalling cascade. The tyrosine kinase activity of the EGFR was a prerequisite for this stimulation, since treatment of cells with a synthetic inhibitor of this receptor, AG1478, completely abrogated shedding. The metalloproteinase mediating Met cleavage was specifically inhibited by the tissue inhibitor of metalloproteinases (TIMP)-3, but not by TIMP-1 or TIMP-2. Furthermore, the level of Met shedding could be modulated by different cell-matrix interactions. Our results indicate that ectodomain shedding is a highly regulated process that can be stimulated by EGFR signalling pathways and integrin ligation.
Similar articles
- Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.
Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M. Fitzgerald ML, et al. J Cell Biol. 2000 Feb 21;148(4):811-24. doi: 10.1083/jcb.148.4.811. J Cell Biol. 2000. PMID: 10684261 Free PMC article. - Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP, Yu FS. Xu KP, et al. Invest Ophthalmol Vis Sci. 2007 May;48(5):2242-8. doi: 10.1167/iovs.06-0560. Invest Ophthalmol Vis Sci. 2007. PMID: 17460286 Free PMC article. - Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors.
Wu J, Cunnick JM. Wu J, et al. Biochim Biophys Acta. 2002 May 23;1582(1-3):100-6. doi: 10.1016/s1388-1981(02)00143-9. Biochim Biophys Acta. 2002. PMID: 12069816 Review. - Metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor and its pathophysiological roles.
Higashiyama S. Higashiyama S. Protein Pept Lett. 2004 Oct;11(5):443-50. doi: 10.2174/0929866043406562. Protein Pept Lett. 2004. PMID: 15544565 Review.
Cited by
- The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies.
De Herdt MJ, van der Steen B, Baatenburg de Jong RJ, Looijenga LHJ, Koljenović S, Hardillo JA. De Herdt MJ, et al. Cancers (Basel). 2022 Mar 15;14(6):1491. doi: 10.3390/cancers14061491. Cancers (Basel). 2022. PMID: 35326642 Free PMC article. - Proteolytic Cleavage of Receptor Tyrosine Kinases.
Huang H. Huang H. Biomolecules. 2021 Apr 29;11(5):660. doi: 10.3390/biom11050660. Biomolecules. 2021. PMID: 33947097 Free PMC article. Review. - Constitutive and Regulated Shedding of Soluble FGF Receptors Releases Biologically Active Inhibitors of FGF-2.
Hanneken A, Mercado M, Maher P. Hanneken A, et al. Int J Mol Sci. 2021 Mar 8;22(5):2712. doi: 10.3390/ijms22052712. Int J Mol Sci. 2021. PMID: 33800200 Free PMC article. - The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM, Link T, Goeckenjan M, Wimberger P, Kuhlmann JD. Klotz DM, et al. Mol Oncol. 2021 Sep;15(9):2491-2503. doi: 10.1002/1878-0261.12939. Epub 2021 Apr 7. Mol Oncol. 2021. PMID: 33690968 Free PMC article. - Current advances of targeting HGF/c-Met pathway in gastric cancer.
Anestis A, Zoi I, Karamouzis MV. Anestis A, et al. Ann Transl Med. 2018 Jun;6(12):247. doi: 10.21037/atm.2018.04.42. Ann Transl Med. 2018. PMID: 30069449 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous